Y-mAbs Therapeutics Investor Relations Material
Latest events
Status Update
Y-mAbs Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Y-mAbs Therapeutics Inc
Access all reports
Y-mAbs Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of antibody-based therapies for the treatment of cancer. The company specializes in creating monoclonal antibody treatments that target tumors in pediatric and adult patients. Y-mAbs leverages its expertise in immunotherapies to advance a pipeline of innovative treatments designed to improve survival rates and patient outcomes in oncology. Its focus is primarily on addressing rare and difficult-to-treat cancers. The company is headquartered in New York, New York, and its shares are listed on the NASDAQ.
Key slides for Y-mAbs Therapeutics Inc
Corporate Presentation
Y-mAbs Therapeutics Inc
Status Update
Y-mAbs Therapeutics Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
YMAB
Country
🇺🇸 United States